AZOLOL (Stanozolol) 5 mg
5 mg · 400 tablets · AZOLOL (Stanozolol) delivers a high-anabolic, non-aromatizing research profile ideal for studies on AR-driven protein synthesis, lean-tissue modeling, and hepatic metabolism of 17-α-alkylated oral steroids.
€ 79.00
Beschreibung
AZOLOL (Stanozolol) 5 mg
Brand: The British Dispensary Co. LTD
Category: Oral AAS Research Compound
Content: 400 tablets | 5 mg per tablet (2,000 mg total)
Price: €79
Manufactured in: Thailand
🧪 Product Overview
Stanozolol 5 mg, sold under the research label AZOLOL, is a synthetic anabolic– androgenic steroid (AAS)
derived from dihydrotestosterone (DHT). Its 17-α-alkylated design allows stable oral absorption and makes it
a preferred reference standard for exploring androgen receptor (AR) modulation, lean-mass biology,
and hepatic metabolism associated with oral anabolic steroids.
Historically known as Winstrol, stanozolol provides a robust anabolic signal with relatively mild androgenic activity.
It is widely incorporated into studies focusing on selective anabolic activation, non-aromatizing steroid pathways,
and toxicology models related to liver enzyme induction and hepatocellular stress.
✅ Key Research Highlights
Anabolic signal amplification:
Increases protein synthesis and anabolic gene transcription through AR agonism.
Lean-tissue modeling:
Commonly used in studies involving fat-free mass, metabolic efficiency, and performance-related tissue adaptations.
Hepatic metabolism marker:
As a 17-α-alkylated steroid, stanozolol is frequently used to investigate cholestatic patterns, enzyme elevation,
and liver-injury signaling mechanisms.
Comparative mechanistic studies:
Benchmarked against oxandrolone, methandienone, and similar AAS to evaluate differential anabolic/androgenic ratios.
🧬 Suggested Laboratory Applications
- Androgen receptor–mediated transcription and protein synthesis modeling
- Lean-mass and performance metabolism research
- Non-aromatizing anabolic pathway analysis
- Hepatotoxicity screening for 17-α-alkylated oral steroids
- Comparative AAS potency and toxicity profiling
📊 Technical Specifications
| Field | Value |
|---|---|
| Chemical Name | Stanozolol |
| Synonyms | Winstrol, Stromba, 17α-Methyl-5α-androstano[3,2-c]pyrazol-17β-ol |
| Molecular Formula | C21H32N2O |
| Molecular Weight | 328.50 g/mol |
| CAS Number | 10418-03-8 |
| PubChem CID | 25249 |
| Class | Synthetic Anabolic-Androgenic Steroid (AAS) |
| Mechanism | Androgen receptor agonist; protein synthesis modulation |
| Form | Oral tablet (5 mg) |
| Manufacturer | The British Dispensary Co. LTD |
| Country of Origin | Thailand |
| Packaging | 400 tablets (5 mg each) |
| Total Content | 2,000 mg active compound |
❄️ PubChem-Supported Research Insights
- Strong AR-binding affinity produces significant anabolic transcriptional activity
- Does not aromatize — supports isolated androgen pathway research
- 17-α-alkylation introduces hepatic stress markers useful for toxicology assays
- Demonstrates consistent oral bioavailability for pharmacokinetic modeling
- Common model compound for performance-enhancement metabolism studies
⚠️ Documented Research Side Effects
- Elevations in liver enzymes; cholestatic patterns
- Altered lipid metabolism (↓ HDL, ↑ LDL)
- Androgenic markers: acne, hair-growth shifts, sebaceous activity
- Reproductive hormone suppression in long-term models
🧯 Handling & Compliance
For Research Use Only — Not for human or veterinary consumption.
Store sealed, below 30 °C, protected from moisture and light.
Stanozolol is listed under WADA S1 prohibited anabolic agents.
Acquisition and handling require qualified researcher compliance with applicable regulations.
There are no reviews yet.
